Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

Eastern Bank increased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 145.8% in the 3rd quarter, according ...